Sage Journals: Discover world-class research

Open access

Research article

First published 2016-11

Detection of anti-infliximab antibodies is impacted by antibody titer,infliximab level and IgG4 antibodies: a systematic comparison of three different assays

Joana Afonso, Susana Lopes, Raquel Gonçalves [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2016-7

Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients’ infliximab therapeutic drug monitoring

Nicola L Barlow, Pervaz Mohammed, Jonathan D Berg

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open access

Research article

First published 2020

Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays

Cátia Rocha, Paula Lago, Samuel Fernandes [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Dynamics of serum concentrations of antibodies to infliximab: a new approach for predicting secondary loss of response in inflammatory bowel diseases

Melina K. Grasmeier, Anna F. Langmann, Peter Langmann [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2023

Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn’s disease patients with secondary loss of response

Eun Sil Kim, Yiyoung Kwon, Yon Ho Choe [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2003-9

Use of Infliximab,an Anti-Tumor Necrosis Alpha Antibody,for Inflammatory Dermatoses

Anna Drosou, Robert S. Kirsner, Esperanza Welsh [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2009-06

Infliximab in the Treatment of Anti-CTLA4 Antibody (Ipilimumab) Induced Immune-Related Colitis

David R. Minor, Kevin Chin, Mohammed Kashani-Sabet

Cancer Biotherapy and Radiopharmaceuticals

Free access

Letter

First published 2010-7

Sudden Progression from Impaired Glucose Tolerance to Type 2 Diabetes after Discontinuation of Administration of Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab

F. Ursini, E. Succurro, A. Grembiale [...]

International Journal of Immunopathology and Pharmacology

Free access

Research article

First published 2011-4

Anti-TNF-α Antibody (Infliximab) Therapy Supports the Recovery of eNOS and VEGFR2 Protein Expression in Endothelial Cells

I. Altorjay, Z. Veréb, Z. Serfőző [...]

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2021

Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients

Sonia Facchin, Andrea Buda, Romilda Cardin [...]

Therapeutic Advances in Gastroenterology

Search results